Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2023-03-08 00:00:00 ET · period of report 2023-03-06 · accession 0001104659-23-030097 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-08 | 2023-03-06 | AMPH | Liawatidewi Yakob | EVP Corp Admin Center | A - Grant | $0.00 | +12.8K | 74.4K | +21% | $0 |
| D | 2023-03-08 | 2023-03-06 | AMPH | Liawatidewi Yakob | EVP Corp Admin Center | A - Grant | $0.00 | +26.9K | 26.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-06 | A | A | 12,752 | $0.00 | 74,359 | D | — | — | (F1) The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on March 6, 2024. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2023-03-06 | A | A | 26,873 | $0.00 | 26,873 | D | $35.13 · — to 2033-03-06 | 26,873 Common Stock | (F3) The shares subject to the option vest in four equal annual installments beginning on March 6, 2024. |